EliteTrading

News today with a pop, and now gap has filled. Watch for volume inflow and a continuation. 📈 $ARTL FULLY FUNDED STUDY + CLINICAL MOMENTUM BUILDING. Artelo Biosciences is stacking multiple bullish catalysts with its insane pipeline! 🔬 Clinical Progress: ART26.12 (pain program) ▪️ Positive Phase 1 human data ▪️ Favorable safety + dosing profile ⏳️ Moving toward next-stage trials in 2026 ART27.13 (cancer cachexia) ▪️ Positive Phase 2 interim results ▪️ Improved body weight + activity vs placebo ▪️ Large unmet need in oncology space 💰 NEW CATALYST: FULLY FUNDED GLAUCOMA STUDY Third party funded clinical study announced, expanding pipeline into $16B+ glaucoma market.No funding risk for this program. 🧠 CBD BREAKTHROUGH ANGLE (ART12.11) Proprietary pharma grade CBD candidate which improved bioavailability vs standard CBD.. now positioned for clinical trials! My Thoughts: Multiple opportunitiesin a massive and growing industry from (pain, cancer, CBD, glaucoma)! Positive clinical data across programs + FULLY funded, so LOW dilution risk. News Link: elite.finviz.com/news/320044/ar…⁠ Peers - $IMNN $ITRM $ATON $BFRI $LIAN $JAGX $CNSP $XRTX $SNOA $IGC $ZYNE $ACAD Communicated-Disclaimer- tinyurl.com/yyvaf8p6

@JulesTradesInc Hot 🔥

$CVX 📊 Setup Overview ▪️ Clear bullish channel forming ▪️ Consistent higher highs + higher lows ▪️ Volume picking up on moves higher ▪️ Riding above key moving averages 🎯 Trade Plan ▪️ Key Level: $200 must hold ▪️ Upside Targets: $215 - $225 ▪️ Bias: Bullish continuation $SPX $QQQ $NVDA $SPY

🚨 Noteable charts with strength to track into end of day. $PAYS $MKDW $SIDU

🚨 Elite Market Momentum Snapshot 🚀 Top Gainers $RMSG $ROMA $PAYS $MKDW $SIDU $BZAI 💎 New Highs $ROMA $ELVN $SATL $MPTI 📊 Market Snapshot ▪️ $SPY → $660.9 (+1.9%) ▪️ Gold #Gold → $2,180 (+0.4%) ▪️ Silver #Silver → $24.5 (+0.6%) ▪️ Oil (WTI) → $81.5 (+0.8%) ▪️ Bitcoin #Bitcoin → $67,000 (+2.1%)

Banger .. 655.69🤑

$SPX $SPY GAP ⤵️👀

NEWS today! 💰 $ARTL BULL CASE .. Massive target market exceeding 120 BILLION dollars for Pain Management, Cancer, Glaucoma! 🌎 Global Market Size: ▪️ Pain Management: $80B+ ▪️ Cancer Support (Cachexia): $3B–$5B+ ▪️ CBD / Cannabinoid Pharma: $20B–$50B+ (a fast growing industry) ▪️ Glaucoma / Eye Care: $15B–$20B+ Catalysts: Multi-Program Pipeline ✔️Massive Market Potential Pain + cancer + eye disease = multi-billion dollar with expansion potential. ✔️ Positive Clinical Signals Encouraging data in all programs. ✔️ Fully Funded Study. Financial backing is often the missing link, but not here! Glaucoma program backed externally so less dilution risk. ✔️ CBD Pharma Angle Pharmaceutical grade CBD equala higher-value vs retail CBD. A #CBD name to watch! Peers - $IMNN $ITRM $ATON $BFRI $LIAN $JAGX $CNSP $XRTX $SNOA $IGC $ZYNE $ACAD Communicated-Disclaimer- tinyurl.com/yyvaf8p6

@JulesTradesInc Absolutely. A low float since RS.

@EliteGainzTrade Solid volume for this low float 👀

🚨 News 🚨 $ARTL SURGING ON $16.3B MARKET EXPANSION + FUNDED STUDY! Artelo is gaining momentum after announcing a major pipeline expansion + capital-efficient clinical move! 🔑 Key Points: ▪️ Entering $16.3B glaucoma market 👉 Expands beyond cancer + pain into a massive new opportunity. ▪️ Fully funded clinical study 👉 Backed by third parties = no direct cost to shareholders ▪️ Pipeline expansion + new indication 👉 Lead drug ART27.13 now targeting multiple indications (cancer + glaucoma). Keep this low float on watch! Peers - $IMNN $ITRM $ATON $BFRI $LIAN $JAGX $CNSP $XRTX $SNOA $IGC $ZYNE $ACAD Communicated-Disclaimer- tinyurl.com/yyvaf8p6

@traderjon01 Great stuff! Potential for a move on this low float.

$ARTL watching this one after the big recent move! 🔥 Entered into the Glaucoma market on 3/18. This is a fully funded clinical study agreement. 🔥 They just completed a reverse split this month. This reduced the float to about 708k shares. 🔥 ART12.11 (CBD cocrystal) outperforms standard CBD in absorption and consistency. 🔥 Near term catalyst: Enrollment for the ART26.12 MAD study is set for Q3 2026. 🔥They have 3 main drugs, I'll dive into each one in the next tweet. ART27.13, ART26.12 , and ART12.11. ⚠️ Small but open S-1 Disclaimer: tinyurl.com/traderjon01-ar… #advertisement ~ Paid $400 cash by a third party on 3/25/2026 for this promotion. I don't own any shares. Penny stocks are extremely high risk and volatile — NFA. Do your own due diligence. ~ $TERN $JNJ $MRK

@stocksrockman This one has potential to go big! Watching.

*Advertisement* $ARTL last run was absolutely insane. It was "the talk of the town." Now that we are back to baseline, do you think you'll bank again here? After its recent reverse split, this can really go wild again and again. Let's recap the positives: ART26.12 (Pain — non-opioid) • First-in-human Phase 1 completed • Safety profile • Predictable PK Significance: • Human validation achieved (key biotech inflection) • Positioned in the non-opioid pain market (high-demand category) ART27.13 (Cancer cachexia) • Positive Phase 2 interim data • Demonstrated: • Weight gain vs placebo • Improved activity • Lean body mass improvement • No FDA-approved treatments in this ART12.11 (CBD pharma platform) • Improved: • Bioavailability • Pharmacokinetics • Consistency vs standard CBD • Regulatory support (UK MHRA) • Preparing for human trials So we have the White House ready to drop a dime bag on the industry as a whole and a nano float with catalysts. Happy trading. ▌ ▌ L │ ▌ F │ ▌ G │ ▌ └─────────────── Support → Trend → ↑

💡IDEA $MRVL FLAGGING .. BREAKOUT watch. Strong after #ER beat, now consolidating in a tight flag pattern as momentum builds. ▫️ Strong post-earnings strength ▫️ Bull flag forming (continuation setup) ▫️ Holding above key moving averages ▫️ Buyers stepping in on dips 📊 Trade Setup Idea ▪️ Trigger: Above $93 ▪️ Target: $100+ ▪️ Support: $89 area $SPX $SPY $QQQ $NVDA

@Farid_313_ @Elite_Edge_Algo Goat 🔥

Both sides got called today Upside hit 500% Downside hit 300% All based on dealer positioning + hedging + @Elite_Edge_Algo’s box break strategy Every premarket the full game plan is laid out by $SPY king @Elite_Edge_Algo If the setup aligns with the algo signal we execute If not we trade the boxes alongside dealer levels where targets are already mapped This is what separates it Not just signals you actually learn how to trade and understand why moves happen Saying this as a member not affiliated at all so you know it’s coming from Heart Real results real edge Join his discord and see for yourself link is in his bio @Elite_Edge_Algo #SPY #SPX #IWM #QQQ #GEX

@JulesTradesInc I love this! Crazy volatility but a few solid winners.

⏳️ End of day Snapshot 🚀 Top Gainers $RBNE $FEED $QNTM $ANNA $CVV $SWMR 💎 New Highs $YDDL $AXTI $TLYS $ASRT

@traderjon01 @unusual_whales Right? Same .. this one made me laugh out loud. I thought things looked promising according to Trump, then this. Haha

@EliteGainzTrade @unusual_whales I can't keep up 😂

BREAKING: US and Iran may hold high level peace talks Thursday, per Axios

@traderjon01 @unusual_whales Exactly lol. This is nuts!

@unusual_whales Maybe yes maybe no

💪🤑

$SPX $SPY Booom! Our algo paying yet again. Soon to be live streamed on Youtube for FREE. 650 support. Key range to watch. Open gaps above and below. Follow for more! Please like and reshare. $QQQ $NVDA $AAPL